CellType
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
Y Combinator
yc-company-directory #5981CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
sourceCellType is classified as AI agents from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.
Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.
Companies similar to CellType
A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.
Parallel Bio
match 79Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of nov
shared extracted concepts: human biology; shared product terms: drug, discovery, pipeline, biological; shared affiliation: Y Combinator
Strand AI
match 69Strand AI develops foundation models to generate missing bio-data about patients. With this imputed data, pharmaceutical companies can select better patients for their drug trials and shave months from their drug launch timelines. We’ve already trained a multimodal foundation model that integrates spatial biology modalities, beating SOTA at a fraction of the cost.
shared extracted concept terms: foundation, model; shared product terms: drug, foundation, model, biology; shared affiliation: Y Combinator
Origami Therapeutics, Inc.
match 69Origami Therapeutics, Inc. is a biotech company developing novel protein degraders with potential to delay or halt disease progression by eliminating toxic proteins from the body. Our drug discovery platform leverages our proprietary human disease models developed to select the small molecules with the best chance of clinical success. Our first indication is Huntington’s disease, a debilitating, progressive and ultimately fatal disorder caused by a genetic mutation. We have already identified sm
shared extracted concept terms: human, model; shared product terms: drug, discovery, model, human; shared affiliation: Y Combinator
Tamarind Bio
match 61Tamarind Bio is a website and API which allows scientists to use computational biology tools at scale using a simple interface. On Tamarind, scientists can use ML models like AlphaFold to design and simulate molecules by simply selecting inputs instead of or setting up a high performance computing environment or dealing with DevOps. Tamarind is used by tens of thousands researchers in large pharma companies, top biotechs, and academic institutions.
shared extracted concept terms: biology, model; shared product terms: top, model, simulate, biology; shared affiliation: Y Combinator
AbInitio Bio
match 53Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
shared extracted concept terms: model, foundation; shared product terms: foundation, model, validat, pharma; shared affiliation: Y Combinator
Standard Signal
match 33Standard Signal is the first hedge fund that researches and executes trades purely with AI. Our custom models discover and trade on new fundamental truths about the world before humans can.
shared product terms: signal, model, discover, human; shared affiliation: Y Combinator